566

rezultat(e)

Cuvânt (cuvinte)
Tipul publicației
Domeniul tematic
Autor
Cuvânt-cheie
Data

EU4Health programme 2021-2027

03-03-2021

On 28 May 2020, the European Commission adopted a proposal for a regulation on the establishment of a programme for the Union's action in the field of health for the 2021-2027 period (EU4Health programme). Interinstitutional negotiations between the European Parliament and the Council were concluded on 14 December 2020 with a provisional agreement on the programme, including a budget of €5.1 billion. Parliament's Committee on the Environment, Public Health and Food Safety endorsed the final compromise ...

On 28 May 2020, the European Commission adopted a proposal for a regulation on the establishment of a programme for the Union's action in the field of health for the 2021-2027 period (EU4Health programme). Interinstitutional negotiations between the European Parliament and the Council were concluded on 14 December 2020 with a provisional agreement on the programme, including a budget of €5.1 billion. Parliament's Committee on the Environment, Public Health and Food Safety endorsed the final compromise on 15 January 2021. Parliament's first-reading vote is expected during the March I plenary session.

Outcome of the European Council video-conference of 25 February 2021

26-02-2021

For the tenth time since the outbreak of the coronavirus crisis, the European Council met by video-conference, however this time in two separate sessions. The first, on 25 February, dealing with the ongoing coronavirus pandemic and ways of increasing the EU’s health resilience, is covered in this paper, while the second, the following morning, addressed security and defence as well as the southern neighbourhood, and is covered by a separate paper. Regarding the pandemic, EU leaders called for acceleration ...

For the tenth time since the outbreak of the coronavirus crisis, the European Council met by video-conference, however this time in two separate sessions. The first, on 25 February, dealing with the ongoing coronavirus pandemic and ways of increasing the EU’s health resilience, is covered in this paper, while the second, the following morning, addressed security and defence as well as the southern neighbourhood, and is covered by a separate paper. Regarding the pandemic, EU leaders called for acceleration in the authorisation, production and distribution of vaccines, reiterated their solidarity with third countries, and acknowledged that non-essential travel still needed to be restricted while ensuring the unhindered flow of goods and services within the single market. To strengthen the EU’s resilience to future health emergencies, EU leaders will seek to improve coordination to ensure better prevention, preparedness and response. However, further EU integration in health policy was excluded, with the conclusions stressing that these actions should be carried out ‘in line with the Union competences under the Treaties’. EU leaders also called on the Commission to draw up a report on the lessons learned from this crisis, to take forward the work on the European health union, and underlined the need for a global approach, including an international treaty on pandemics.

Coronavirus: Uncertainty and discontent [What Think Tanks are thinking]

04-02-2021

As the latest wave of the coronavirus pandemic intensifies and some highly infectious new mutations of the virus spread, a growing number of countries have increased restrictions on travel and some lockdowns have been intensified. Whilst a series of vaccines are progressively gaining official approval, and their roll-out has started, pharmaceutical companies struggle with production capacity issues, the effectiveness of the vaccines on mutations is still uncertain, and a broader debate is opening ...

As the latest wave of the coronavirus pandemic intensifies and some highly infectious new mutations of the virus spread, a growing number of countries have increased restrictions on travel and some lockdowns have been intensified. Whilst a series of vaccines are progressively gaining official approval, and their roll-out has started, pharmaceutical companies struggle with production capacity issues, the effectiveness of the vaccines on mutations is still uncertain, and a broader debate is opening up on the global fairness of vaccine distribution beyond the ‘first’ world. This note offers links to recent commentaries, studies and reports from international think tanks on the coronavirus and related issues. More studies on the topics can be found in a previous edition in this series, published in December 2020.

Policy Departments’ Monthly Highlights - February 2021

04-02-2021

The Monthly Highlights publication provides an overview, at a glance, of the on-going work of the policy departments, including a selection of the latest and forthcoming publications, and a list of future events.

The Monthly Highlights publication provides an overview, at a glance, of the on-going work of the policy departments, including a selection of the latest and forthcoming publications, and a list of future events.

EU4Health programme

03-02-2021

On 28 May 2020, the European Commission adopted a proposal for a regulation on a new health programme (EU4Health) for 2021 to 2027. Announced as part of the Next Generation EU (NGEU) recovery instrument, according to the Commission, the EU4Health programme is intended to boost the EU's preparedness for major cross-border health threats and improve health systems' resilience. EU4Health would be a stand-alone, dedicated funding programme with an originally proposed budget of €10.4 billion (in current ...

On 28 May 2020, the European Commission adopted a proposal for a regulation on a new health programme (EU4Health) for 2021 to 2027. Announced as part of the Next Generation EU (NGEU) recovery instrument, according to the Commission, the EU4Health programme is intended to boost the EU's preparedness for major cross-border health threats and improve health systems' resilience. EU4Health would be a stand-alone, dedicated funding programme with an originally proposed budget of €10.4 billion (in current prices). However, during the negotiations on the 2021-2027 multiannual financial framework (MFF) and NGEU, the budget for EU4Health was revised downwards, with the July 2020 European Council conclusions allocating the programme €1.7 billion. On 14 December 2020, Parliament and Council reached a provisional agreement on the programme, including a budget of €5.1 billion. Stakeholders had broadly welcomed the proposal, but generally regretted the European Council's reduction of the financial envelope allocated to it. The co-legislators' December agreement on an increased budget was thus positively received. The first-reading vote in Parliament's plenary on the text is expected in plenary in March. Second edition. The 'EU Legislation in Progress' briefings are updated at key stages throughout the legislative procedure.

Covid-19 vaccination campaigns: The public dimension

29-01-2021

The arrival of the Covid-19 vaccines marks a turning point in the fight against the coronavirus pandemic. For European Commission President Ursula von der Leyen, vaccination is about self protection and solidarity. For many people, it is also about trust. Some are hesitant to get vaccinated, while others are against vaccination on principle. According to estimates, coverage of at least 60 % to 75 % is needed to establish population immunity through vaccination. Polls show that sizeable numbers of ...

The arrival of the Covid-19 vaccines marks a turning point in the fight against the coronavirus pandemic. For European Commission President Ursula von der Leyen, vaccination is about self protection and solidarity. For many people, it is also about trust. Some are hesitant to get vaccinated, while others are against vaccination on principle. According to estimates, coverage of at least 60 % to 75 % is needed to establish population immunity through vaccination. Polls show that sizeable numbers of people in the EU are hesitant − or even opposed − to vaccination in general. As regards Covid-19 vaccination, surveys suggest that Europeans are among the most sceptical in the world. According to the World Health Organization, vaccine hesitancy is complex and context-specific, varying across time, place and vaccine. Science has identified several behavioural factors underpinning vaccine uptake. Vaccine scepticism can also be linked to trust in government and is associated with certain political mindsets. Many commentators agree that Covid-19 vaccine communication is a collective endeavour that should ideally involve institutional actors, healthcare professionals, scientists, journalists and people with standing in communities. There is a need to engage with the wider public, in particular with groups that have a low level of trust in scientists and are less favourable to vaccines. It is considered key to move towards an open dialogue that respects people's emotions, and to understand the individual values behind doubters' fears. Reaching diverse populations is deemed instrumental, as is involving political and community leaders in communication strategies. The December 2020 European Council conclusions stressed the importance of providing clear factual information on Covid-19 vaccines and countering disinformation. The European Commission is set to roll out a two-phase vaccine communication campaign complementing the Member States' efforts. The European Parliament has insisted on the need to counter the spread of unreliable, misleading and unscientific information on vaccination, and Members have repeatedly called for more transparency on the EU advance purchase agreements with vaccine developers.

How the COVID-19 crisis has affected security and defence-related aspects of the EU

27-01-2021

This paper looks at how the COVID-19 pandemic has directly and indirectly affected European security and defence. It documents how missions and operations of the Common Security and Defence Policy (CSDP) were directly impacted. It finds that COVID-19 has accentuated already recognised capacity shortfalls of the CSDP, such as strategic airlift, secure communications and command and control. Defence spending through EU instruments, and to a lesser extent at national level, has come under pressure although ...

This paper looks at how the COVID-19 pandemic has directly and indirectly affected European security and defence. It documents how missions and operations of the Common Security and Defence Policy (CSDP) were directly impacted. It finds that COVID-19 has accentuated already recognised capacity shortfalls of the CSDP, such as strategic airlift, secure communications and command and control. Defence spending through EU instruments, and to a lesser extent at national level, has come under pressure although it may still escape post-2008 style cuts. The pandemic revealed the vulnerabilities of Member States’ infrastructure and supply chains, and the limited competences of the EU in supporting Member States’ management of public health emergencies. COVID-19 tends to act as a threat multiplier and source of instability, particularly in low-income countries already affected by socio-economic imbalances and governance problems. The pandemic is likely to accelerate existing trends, including the declining share of the US and the EU in the world economy compared to Asia, intensifying concerns about China’s growing assertiveness, growing attention to IT security and cyber capabilities, and the interconnection between conventional and unconventional security risks. This analysis also looks at which lessons the EU should learn in order to better manage and prepare for such crises. At a strategic level, the EU needs to invest in lesson learning exercises with the European Parliament playing a key role in making the learning publicly accessible. It should also be proactive in shaping international discourses about international governance and the role of the EU post COVID-19. Furthermore, the paper elaborates 19 short and longer-term recommendations, for instance, on how CSDP missions can become more resilient in public health emergencies and which capability shortfalls need addressing most; how defence spending can be made more efficient and better targeted; or how the EU can help to better coordinate military support to civilian authorities. Finally, it advocates investment in health intelligence and better managing the biosecurity risks arising from growing access to dual-use technologies. The EU should forge a preventive approach to future pandemics and associated risks and embrace a comprehensive approach to security and resilience. Yet, one should not lose sight of the distinctive function of the CSDP and what it can currently deliver.

Autor extern

Christoph O. Meyer, Sophia Besch, Prof. Martin Bricknell, Dr Ben Jones Christoph O. MEYER, Martin BRICKNELL, Ramon PACHECO PARDO, Ben JONES.

Air pollution and COVID-19

12-01-2021

This study is about the effects of air pollution on health, notably COVID-19. The COVID-19 pandemic continues to wreak havoc in many areas of the world. The infection spreads through person-to-person contact. Transmission and prognosis, once infected, are potentially influenced by many factors, including air pollution. Studies have suggested that air pollution increases the incidence and the severity of the disease. However, the current data are too limited to be certain. Especially the quantitative ...

This study is about the effects of air pollution on health, notably COVID-19. The COVID-19 pandemic continues to wreak havoc in many areas of the world. The infection spreads through person-to-person contact. Transmission and prognosis, once infected, are potentially influenced by many factors, including air pollution. Studies have suggested that air pollution increases the incidence and the severity of the disease. However, the current data are too limited to be certain. Especially the quantitative contribution of air pollution to the disease is still very uncertain.

Autor extern

Bert BRUNEKREEF et al.

The use of pesticides in developing countries and their impact on health and the right to food

08-01-2021

This study provides a broad perspective on the main trends regarding the use of pesticides in developing countries and their impacts on human health and food security. Information is provided on the challenges of controlling these hazardous substances, along with the extent to which pesticides banned within the European Union (EU) are exported to third countries. The analysis assesses the factors behind the continuation of these exports, along with the rising demand for better controls. Recommendations ...

This study provides a broad perspective on the main trends regarding the use of pesticides in developing countries and their impacts on human health and food security. Information is provided on the challenges of controlling these hazardous substances, along with the extent to which pesticides banned within the European Union (EU) are exported to third countries. The analysis assesses the factors behind the continuation of these exports, along with the rising demand for better controls. Recommendations are intended to improve the ability for all people, including future generations, to have access to healthy food in line with United Nations declarations. These recommendations include collaborating with the Rotterdam Convention to strengthen capacity building programmes and the use of the knowledge base maintained by the Convention; supporting collaboration among developing countries to strengthen pesticide risk regulation; explore options to make regulatory risk data more transparent and accessible; strengthen research and education in alternatives to pesticides; stop all exports of crop protection products banned in the EU; only allow the export of severely restricted pesticides if these are regulated accordingly and used properly in the importing country; and support the re-evaluation of pesticide registrations in developing countries to be in line with FAO/WHO Code of Conduct.

Autor extern

Swagata SARKAR, Juliana DIAS BERNARDES GIL, James KEELEY, Niklas MÖHRING, Kees JANSEN

Ten issues to watch in 2021

06-01-2021

This is the fifth edition of an annual EPRS publication aimed at identifying and framing some of the key issues and policy areas that are likely to feature prominently on the political agenda of the European Union over the coming year. The topics analysed are: the Covid-19 race for a vaccine; the recovery plan; access to food; inequality; challenges for culture and the performing arts; a digital boost for the circular economy; critical raw materials; border controls; Turkey and the eastern Mediterranean ...

This is the fifth edition of an annual EPRS publication aimed at identifying and framing some of the key issues and policy areas that are likely to feature prominently on the political agenda of the European Union over the coming year. The topics analysed are: the Covid-19 race for a vaccine; the recovery plan; access to food; inequality; challenges for culture and the performing arts; a digital boost for the circular economy; critical raw materials; border controls; Turkey and the eastern Mediterranean; and the new US administration.

Evenimente viitoare

15-03-2021
EPRS online Book Talk with Vivien Schmidt: Legitimacy and power in the EU
Alt eveniment -
EPRS
16-03-2021
EPRS online policy roundtable: New European Bauhaus
Alt eveniment -
EPRS
17-03-2021
Hearing on Responsibilities of transport operators and other private stakeholders
Audiere -
ANIT

Parteneri